[ad_1]
Qiryat Shmona, Israel, June 10, 2021: MigVax Ltd., a startup company developing an oral subunit vaccine against COVID-19, today announced promising results from preclinical tests that demonstrated the effectivity of its MigVax-101 subunit oral vaccine as a booster for previously vaccinated persons.
Read more here.
[ad_2]
Source link